URIFLEX FAST ACTING ANALGESIC PAIN RELIEF- menthol cream 
Rejuvica LLC

----------

URIFLEX Fast Acting Analgesic Pain Relief Cream

Drug Facts

Active Ingredients

Menthol 4.50%

Purposes

External Analgesic

Uses:

For temporary relief of minor aches and pains associated with simple backache, arthritis, bruises, sprains, and strains.

Warnings:

For External Use Only. Avoid Contact With Eyes.

DO NOT Apply

to Open Wounds or Damaged Skin. If symptoms persist for more than seven days, discontinue use and consult physician.

KEEP OUT OF REACH OF CHILDREN.

If swallowed, consult physician. Do not bandage tightly.

If pregnant or breast feeding,

contact physician prior to use.

Directions:

Apply directly to affected area. Do not use more than four times per day.

Other Ingredients:

Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Aloe Barbadensis Leaf (Aloe Vera Gel) Juice, Aqua (Deionized Water), Cetyl Alcohol, Diazolidinyl Urea, Isopropyl Myristate, Methyl Paraben, Methyl Salicylate, PEG-8, Propyl Paraber, Propylene Glycol, Sodium Laruyl Sulfate, Triethanolamine.

Package Labeling:

Label

URIFLEX FAST ACTING ANALGESIC PAIN RELIEF 
menthol cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73168-004
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL45 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
WATER (UNII: 059QF0KO0R)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
METHYL SALICYLATE (UNII: LAV5U5022Y)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
TROLAMINE (UNII: 9O3K93S3TK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73168-004-00118 mL in 1 JAR; Type 0: Not a Combination Product05/20/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01705/20/2019
Labeler - Rejuvica LLC (062848492)

Revised: 11/2023
Document Id: 09751fc7-6657-c196-e063-6294a90a4a57
Set id: fb78f705-b838-461d-b42c-8c98d3ca5d09
Version: 2
Effective Time: 20231105
 
Rejuvica LLC